Crossmark

ABO hemolytic disease of the fetus and newborn: thirteen years of data after implementing a universal bilirubin screening and management program

Crossref DOI link: https://doi.org/10.1038/s41372-018-0048-4

Published Online: 2018-02-06

Published Print: 2018-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Christensen, R. D.

Baer, V. L.

MacQueen, B. C.

O’Brien, E. A.

Ilstrup, S. J.
License Information

Text and Data Mining valid from 2018-02-06
More Information

Article History

Received: 27 July 2017

Revised: 1 December 2017

Accepted: 12 December 2017

First Online: 6 February 2018

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.